Mary Murphy
Papers
4
Total Citations
82
H-Index
4
About
Mary Murphy is a pioneering researcher at the intersection of stem cell biology and advanced manufacturing technologies, with a particular focus on automating the production of cell-based therapies for regenerative medicine. Her work centers on mesenchymal stromal cells (MSCs), which hold significant promise for treating chronic and life-threatening conditions, and on developing scalable, clinically compliant manufacturing systems to bring these therapies to patients at scale. Murphy's most influential contributions include her leadership in the AUTOSTEM project, a landmark initiative that produced a closed, robotic platform capable of manufacturing bone marrow-derived MSCs to clinical-grade standards — a critical step toward replacing costly and error-prone manual processes. Her 2016 paper on automated robotic factory design has attracted over 350 citations, underscoring its foundational impact on the field. Her continued refinement of these systems, culminating in the 2022 "needle to needle" robot-assisted manufacturing framework, demonstrates a sustained commitment to end-to-end automation of advanced therapeutic medicinal products (ATMPs). Together, Murphy's body of work has helped transform cell therapy manufacturing from a largely artisanal process into a reproducible, scalable discipline, directly accelerating the clinical translation of regenerative medicine.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4